News Summary: Drug news ups Merck, Bristol stocks

Published



ENCOURAGING RESULTS: Early testing of a new type of cancer-fighting drugs, under development by Merck, Bristol-Myers Squibb and Roche, shows they appear to shrink tumors and extend lives in patients with deadly advanced skin cancer.

NEW STRATEGY: The antibody drugs work by helping the immune system spot cancer cells that otherwise would be “invisible,” so that powerful immune system cells called T-cells can target and destroy the cancer cells.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.